Feedback / Questions
ALZN002 - Alzamend Neuro
https://www.businesswire.com/news/home/20230104005428/en/Alzamend-Neuro-Partners-With-Biorasi-to-Conduct-a-First-in-Human-Randomized-Double-Blind-Placebo-Controlled-Parallel-Group-Phase-IIIA-Clinical-Trial
Jan 4, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next